tirzepatide uric acid reduction study on ingestive behavior in adults with overweight or obesity: a randomized 6-week phase 1 trial Tirzepatide for the treatment of

Category 2 means a compounding pharmacy cannot legally prepare that compound for a patient, even with a valid prescription from a licensed doctor

LCs number of 2 IU/kg rhGH rats was significantly higher than 1 IU/kg rhGH rats

Obesity was associated with 3.7-million deaths worldwide in 2024, and if current trends continue, the number of obese people is projected to double by 2030, according to the WHO

Tirzepatide hits two receptors, and studies show that with tirzepatide, you get about a 32% weight loss compared to 28% with semaglutide. Both are effective

The risk increases even more when GLP-1 analogues are used at higher doses, for longer durations, or for weight loss